Krsnaa Diagnostics Limited (NSE:KRSNAA)
India · Delayed Price · Currency is INR 653.25
-10.85 (-1.63%)
Feb 19, 2026, 2:08 PM IST
Krsnaa Diagnostics Market Cap
Krsnaa Diagnostics has a market cap or net worth of 21.54 billion as of February 18, 2026. Its market cap has decreased by -19.06% in one year.
Market Cap
21.54B
Enterprise Value
23.10B
Revenue
7.66B
Ranking
n/a
PE Ratio
27.15
Stock Price
653.25
Market Cap Chart
Since August 16, 2021, Krsnaa Diagnostics's market cap has decreased from 30.99B to 21.54B, a decrease of -30.48%. That is a compound annual growth rate of -7.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 21.75B | -7.04% |
| Dec 31, 2025 | 23.40B | -18.16% |
| Dec 31, 2024 | 28.59B | 25.42% |
| Dec 29, 2023 | 22.80B | 57.53% |
| Dec 30, 2022 | 14.47B | -37.50% |
| Dec 31, 2021 | 23.15B | -25.28% |
| Aug 16, 2021 | 30.99B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.08T |
| Divi's Laboratories | 1.63T |
| Cipla | 1.10T |
| Apollo Hospitals Enterprise | 1.10T |
| Dishman Carbogen Amcis | 30.82B |
| Medi Assist Healthcare Services | 29.53B |
| Solara Active Pharma Sciences | 24.07B |
| Panacea Biotec | 21.24B |